Genetics Testing
Personalized Treatment through Genetics

How different medicine metabolizes in the body varies greatly among people and may be due in some part to genetic variances in metabolizing enzymes. These genetic variations can cause clinically significant differences in response to prescribed medicines.
Our genetics testing can help clinicians more successfully personalize treatment by identifying patients who may benefit from modifying the drug dosage or selection of certain prescribed opioids, including hydrocodone, codeine, tramadol, oxycodone, and methadone; and benzodiazepines; tricyclic antidepressants, selective serotonin reuptake inhibitors, and serotonin norepinephrine reuptake inhibitors.
Pain Management Personalized to Increase Patient Outcomes

Medicine Metabolism Can Affect Treatment Response

Insufficient pain management
Greater risk for medication interactions
Need for lower to higher dosage
Greater risk for adverse effects
Unexpected UDC results

Improving Patient Care

Using information provided by our genetics testing, physicians can customize treatment plans that lower the changes of patients developing adverse hazards or side effects. While a number of variables can affect how medicine can affect patients, genetics has been shown to play a significant part. Attempting to predict how a patient will react to a specific drug using genetic testing could have a significant influence on the quality of life and care provided to pain management patients.
Medicine that is Personalized

Advancements made in genetic research has increased our understanding of the importance of genetics in medicine and patient care. Personalized medicine utilizes lifestyle, genetics, and other risk factors to customize medical decisions and methods of treatments to individual patients. This personalized treatment helps provide knowledge that aids physicians in prescribing a drug treatment plan with a greater likelihood of a positive outcome for the patient.
Identify the Risk of Adverse Drug Reactions

Based on estimates from the FDA, adverse drug reactions are a leading cause of death in the US. Research shows that variance in genetics can influence how patients react to certain drug treatments. While a genetic predisposition for poor metabolism may be a variable in adverse drug events, the risk is greater when patients receive drugs known to inhibit the metabolic pathways. Our genetics testing services, combined with an understanding of the inhibitory effects of co-administered drugs, gives physicians greater knowledge of potential adverse risks, which can help improve patient outcomes and increase patient care.

Cost Effectiveness

Genetics testing has been shown to reduce healthcare costs and improves clinical outcomes. These savings may be greater when considering indirect costs such as costs related to treating adverse reactions; preventative care and early diagnosis, such as proactive counseling to advocate positive lifestyle changes, offer sources for cost savings for medical professionals.